how long have glp 1 drugs been around GLP-1 History: Has This Drug Used? GLP-1 Drugs and Type 1
Description
However, 2026 has brought exciting new advancements
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
A blood pressure log can help identify patterns and guide medication adjustments
Understanding cartilage protection in OA and injury: A spectrum of possibilities
The anti-inflammatory mechanisms appear to be independent of weight loss or glycemic improvement, suggesting direct immunomodulatory properties
